Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on October 29, 2025
Aclaris Therapeutics to Participate in Three November Healthcare Conferences
WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will …
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for SKINJECT™ in Patients with Gorlin Syndrome
PHILADELPHIA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, …
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
WINSTON-SALEM, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members …
Roadzen Signs Definitive Agreement to Acquire Majority Control of a Commercial Auto Insurance Broker, Expanding Its U.S. Footprint
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the intersection of insurance and mobility, today announced that it has signed a definitive agreement to acquire majority control of a commercial auto …
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
JUPITER, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, …
When XRP Ignites the Market Again — BC DEFI AI Becomes the Calm Core of the New Crypto Cycle
London, Oct. 29, 2025 (GLOBE NEWSWIRE) -- As XRP reclaims the spotlight with surging institutional interest and a renewed rally above $2.60, global investors are once again asking: where can sustainable yield still be found in such a volatile market? While …
Pleasing International Launches RWA Platform “Pleasing Golden,” Introducing Tokenized Gold (PGOLD) and Synthetic Dollar (PUSD)
Singapore, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Pleasing International, a licensed precious-metals enterprise based in Hong Kong, is working with LayerZero and Chainlink to launch Pleasing Golden, an RWA platform redefining how precious metals are traded, …
Why Does Tesla Hold Firmly to $1.3 Billion in Bitcoin While SpaceX Suddenly Moves $400 Million?
Washington, D.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest report from blockchain analytics firm Arkham Intelligence, Elon Musk’s space company SpaceX has once again transferred $133.7 million worth of Bitcoin (BTC). Together with a …
BRKZ to accelerate KSA construction industry with new $30m finance facility as mega projects take off
Riyadh, Oct. 29, 2025 (GLOBE NEWSWIRE) -- With Saudi Arabia preparing to host global events such as Expo 2030 and the FIFA World Cup in 2034, and giga-projects like King Salman Park, Diriyah Gate, Qiddiya, and The Red Sea Project advancing, the country’s …
Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report third quarter 2025 financial results on November 4, 2025 at 9:00am ET, before the open of the U.S. financial markets. The company does …
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025
WATERTOWN, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced …
Kamada to Present at the Stifel 2025 Healthcare Conference
REHOVOT, Israel and Hoboken, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty …
Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025
NEW HAVEN, Conn., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review financial results from …
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty …
What Are the Top Skills in Your City? Plum Unveils New Skills Index for Employers and Job Candidates
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Revolutionary pre-hire assessment provider Plum today announced the Plum Durable Skills Index, 2025 North American Edition. Derived from the voluntary participation of more than 59,000 respondents across 27 …
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025
― Announced encouraging results in July 2025 from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― Enrollment complete in the 20 mg dose cohort (n=12) of the PIONEER trial; on track to provide data …
Amarin Reports Third Quarter 2025 Financial Results
Company completes transition to fully partnered commercialization model across all international markets Q3 2025 performance reflects initial impact of new approach to Europe, ongoing expansion of Rest-of-World demand, continued success in managing US …
Aeluma to Announce First Quarter of Fiscal Year 2026 Financial Results on November 12, 2025
GOLETA, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum computing, today …
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company
Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major Multinational Organization in Recent Months Separate Pre-Clinical …
Verano Announces Third Quarter 2025 Financial Results
CHICAGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the third quarter ended September 30, 2025, which …